Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 428

1.

Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.

Colombel JF, Rutgeerts P, Reinisch W, Esser D, Wang Y, Lang Y, Marano CW, Strauss R, Oddens BJ, Feagan BG, Hanauer SB, Lichtenstein GR, Present D, Sands BE, Sandborn WJ.

Gastroenterology. 2011 Oct;141(4):1194-201. doi: 10.1053/j.gastro.2011.06.054. Epub 2011 Jun 30.

PMID:
21723220
2.

Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.

Yamamoto S, Nakase H, Matsuura M, Honzawa Y, Masuda S, Inui K, Chiba T.

J Gastroenterol Hepatol. 2010 May;25(5):886-91. doi: 10.1111/j.1440-1746.2009.06206.x.

PMID:
20546441
3.

A review of infliximab use in ulcerative colitis.

Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB.

Clin Ther. 2008 Feb;30(2):223-30. doi: 10.1016/j.clinthera.2008.02.014. Review.

PMID:
18343261
4.

Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.

Yamamoto-Furusho JK, Uzcanga LF.

Dig Surg. 2008;25(5):383-6. doi: 10.1159/000170882. Epub 2008 Nov 13.

PMID:
19005257
5.

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.

Rutgeerts P, Diamond RH, Bala M, Olson A, Lichtenstein GR, Bao W, Patel K, Wolf DC, Safdi M, Colombel JF, Lashner B, Hanauer SB.

Gastrointest Endosc. 2006 Mar;63(3):433-42; quiz 464.

PMID:
16500392
6.

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.

Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, Lu J, Horgan K, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF.

Gastroenterology. 2009 Oct;137(4):1250-60; quiz 1520. doi: 10.1053/j.gastro.2009.06.061. Epub 2009 Jul 28.

PMID:
19596014
7.

Infliximab efficacy in pediatric ulcerative colitis.

Eidelwein AP, Cuffari C, Abadom V, Oliva-Hemker M.

Inflamm Bowel Dis. 2005 Mar;11(3):213-8.

PMID:
15735427
8.

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.

Frøslie KF, Jahnsen J, Moum BA, Vatn MH; IBSEN Group.

Gastroenterology. 2007 Aug;133(2):412-22. Epub 2007 Jun 2.

PMID:
17681162
9.

Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.

Garcia-Planella E, Mañosa M, Van Domselaar M, Gordillo J, Zabana Y, Cabré E, López San Román A, Domènech E.

Dig Liver Dis. 2012 Mar;44(3):206-10. doi: 10.1016/j.dld.2011.10.004. Epub 2011 Nov 11.

PMID:
22079262
10.

Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis.

Seow CH, Newman A, Irwin SP, Steinhart AH, Silverberg MS, Greenberg GR.

Gut. 2010 Jan;59(1):49-54. doi: 10.1136/gut.2009.183095. Epub .

PMID:
19651627
11.

Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.

Turner D, Griffiths AM, Veerman G, Johanns J, Damaraju L, Blank M, Hyams J.

Clin Gastroenterol Hepatol. 2013 Nov;11(11):1460-5. doi: 10.1016/j.cgh.2013.04.049. Epub 2013 May 11.

PMID:
23672831
12.

Infliximab for induction and maintenance therapy for ulcerative colitis.

Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF.

N Engl J Med. 2005 Dec 8;353(23):2462-76. Erratum in: N Engl J Med. 2006 May 18;354(20):2200.

13.

Infliximab for patients with refractory ulcerative colitis.

Chey WY.

Inflamm Bowel Dis. 2001 May;7 Suppl 1:S30-3.

PMID:
11380041
14.

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.

Carbonnel F, Colombel JF, Filippi J, Katsanos KH, Peyrin-Biroulet L, Allez M, Nachury M, Novacek G, Danese S, Abitbol V, Bossa F, Moreau J, Bommelaer G, Bourreille A, Fumery M, Roblin X, Reinisch W, Bouhnik Y, Brixi H, Seksik P, Malamut G, Färkkilä M, Coulibaly B, Dewit O, Louis E, Deplanque D, Michetti P, Sarter H, Laharie D; European Crohn's and Colitis Organisation; Groupe d'Étude Thérapeutique des Affections Inflammatoires Digestives.

Gastroenterology. 2016 Feb;150(2):380-8.e4. doi: 10.1053/j.gastro.2015.10.050. Epub 2015 Nov 26.

PMID:
26632520
15.

Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.

Bryant RV, Burger DC, Delo J, Walsh AJ, Thomas S, von Herbay A, Buchel OC, White L, Brain O, Keshav S, Warren BF, Travis SP.

Gut. 2016 Mar;65(3):408-14. doi: 10.1136/gutjnl-2015-309598. Epub 2015 May 18.

PMID:
25986946
16.

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Danielsson A, Verbaan H, Hellström PM, Magnuson A, Curman B.

Gastroenterology. 2005 Jun;128(7):1805-11.

PMID:
15940615
17.

Importance of mucosal healing in ulcerative colitis.

Lichtenstein GR, Rutgeerts P.

Inflamm Bowel Dis. 2010 Feb;16(2):338-46. doi: 10.1002/ibd.20997. Review.

PMID:
19637362
18.

Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis.

Hyams J, Damaraju L, Blank M, Johanns J, Guzzo C, Winter HS, Kugathasan S, Cohen S, Markowitz J, Escher JC, Veereman-Wauters G, Crandall W, Baldassano R, Griffiths A; T72 Study Group.

Clin Gastroenterol Hepatol. 2012 Apr;10(4):391-9.e1. doi: 10.1016/j.cgh.2011.11.026. Epub 2011 Dec 8.

PMID:
22155755
19.

Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience.

Laharie D, Filippi J, Roblin X, Nancey S, Chevaux JB, Hébuterne X, Flourié B, Capdepont M, Peyrin-Biroulet L.

Aliment Pharmacol Ther. 2013 May;37(10):998-1004. doi: 10.1111/apt.12289. Epub 2013 Mar 21.

20.

Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.

Fratila OC, Craciun C.

J Gastrointestin Liver Dis. 2010 Jun;19(2):147-53.

Items per page

Supplemental Content

Write to the Help Desk